Unigene Laboratories, Inc. (UGNE) Announces First Quarter 2013 Financial Results and Provides Corporate Update
5/14/2013 7:22:45 AM
More...
|
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
5/9/2013 10:09:25 AM
More...
|
Victory Park Capital Completes Public Auction of Unigene Laboratories, Inc. (UGNE)'s Peptelligence™ Drug Delivery Platform
4/18/2013 9:26:10 AM
More...
|
Unigene Laboratories, Inc. (UGNE) to Slash 40 Pct of Its Workforce
4/9/2013 7:19:01 AM
More...
|
Unigene Laboratories, Inc. (UGNE) Announces Fourth Quarter and Full-Year 2012 Results
3/12/2013 6:43:33 AM
More...
|
Unigene Laboratories, Inc. (UGNE) Comments on FDA Advisory Committee Review of Salmon Calcitonin
3/7/2013 9:38:48 AM
More...
|
Unigene Laboratories, Inc. (UGNE) Receives 2013 Drug Delivery Partnerships Industry Achievement Award
2/14/2013 8:22:30 AM
More...
|
Unigene Laboratories, Inc. (UGNE) Recieves 2013 Drug Delivery Partnerships Industry Achievement Award
2/13/2013 1:12:25 PM
More...
|
Unigene Laboratories, Inc. (UGNE) to Present at the 17th Annual Drug Delivery Partnerships Meeting
2/7/2013 8:18:26 AM
More...
|
Unigene Laboratories, Inc. (UGNE) Completes Financial Statement Amendment
2/1/2013 9:21:50 AM
More...
|
|